Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Non-cash Items (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Non-cash Items for 15 consecutive years, with $3.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items rose 61.88% year-over-year to $3.8 million, compared with a TTM value of $3.8 million through Sep 2025, up 61.88%, and an annual FY2024 reading of $2.5 million, up 108.0% over the prior year.
  • Non-cash Items was $3.8 million for Q3 2025 at BioRestorative Therapies, up from $3.6 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $1.2 billion in Q1 2021 and bottomed at $294658.0 in Q3 2021.
  • Average Non-cash Items over 5 years is $126.0 million, with a median of $2.0 million recorded in 2024.
  • The sharpest move saw Non-cash Items soared 28956.88% in 2021, then crashed 99.96% in 2022.
  • Year by year, Non-cash Items stood at $349237.0 in 2021, then skyrocketed by 65.68% to $578628.0 in 2022, then soared by 107.65% to $1.2 million in 2023, then surged by 108.0% to $2.5 million in 2024, then skyrocketed by 52.29% to $3.8 million in 2025.
  • Business Quant data shows Non-cash Items for BRTX at $3.8 million in Q3 2025, $3.6 million in Q2 2025, and $3.4 million in Q1 2025.